Mapping Brain Metabolites in Tuberous Sclerosis Complex: A 3T MR Spectroscopic Imaging Study

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Tuberous sclerosis complex (TSC) is a genetic disorder impacting multiple organs, notably the brain.
• Neurologic impairments like cognitive deficits and seizures are common in TSC.
• Limited research exists on brain metabolite alterations in TSC.

Purpose of the Study:

• Investigate neurochemical differences in TSC.
• Analyze metabolites in glioneuronal tubers and normal-appearing brain regions.
• Compare metabolite profiles between TSC patients and healthy controls.

Main Methods:

• Utilized multislice 2D-MR spectroscopic imaging.
• Quantified metabolites: total N-acetylaspartate (tNAA), choline (tCho), creatine (tCr), glutamate/glutamine (Glx), and myo-inositol (mI).
• Examined metabolite ratios in tubers, normal-appearing white matter (WM), and gray matter (GM), and assessed age-related correlations.

Main Results:

• Elevated myo-inositol/creatine (mI/tCr) in WM, GM, and tubers of TSC patients.
• Decreased tNAA/tCr and tCho/tCr in TSC tubers and normal-appearing WM.
• Elevated Glx/tCr in TSC tubers; TSC patients lacked age-related Glx/tCr decreases seen in controls.

Conclusions:

• Identified subtle but significant brain metabolic abnormalities in TSC patients compared to controls.
• Metabolite level variations with age differed between TSC patients and controls.
• Findings offer insights into TSC pathophysiology, warranting further study on neurologic symptom correlations.